BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 941465)

  • 1. [Clinical and ergometric studies on the effectiveness of lidoflazine in the treatment of chronic ischemic heart disease].
    Teichmann W; Vogel HC; Schäbitz J; Schmeisser M; Lukesch KH
    Z Gesamte Inn Med; 1976 Mar; 31(6):161-6. PubMed ID: 941465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation and use of the coronary and anti-arrhythmic drug Lidoflazin. Clinical, electrocardiographic, hemodynamic, and laboratory-chemical studies on 187 patients].
    Lehmann HU; Ghabussi P; Hochrein H
    Med Welt; 1977 Feb; 28(8):386-90. PubMed ID: 321914
    [No Abstract]   [Full Text] [Related]  

  • 3. The pathophysiology of angina pectoris and the effect of lidoflazine.
    Gobel FL; Nordstrom LA; Nelson RR; Wang Y
    Circulation; 1982 Jan; 65(1 Pt 2):I27-32. PubMed ID: 7030519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinium used in the treatment of chronic ischaemic cardiac failures.
    Teichmann W; Schäbitz J; Schmeisser M; Vogel H; Lukesch K
    Ther Hung; 1975; 23(2):43-9. PubMed ID: 810909
    [No Abstract]   [Full Text] [Related]  

  • 5. [Acute effect of lidoflazine on the electrocardiographic agitation discharge in atrial frequency stimulation (studies on patients with stress-induced coronary insufficiency)].
    Lehmann HU; Beck OA; Hochrein H
    Z Kardiol; 1975 May; 64(5):396-410. PubMed ID: 1189535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of lidoflazine on ventricular ectopic activity in chronic ischaemic heart disease.
    Myburgh DP
    S Afr Med J; 1975 Nov; 49(50):2087-90. PubMed ID: 1198246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lidoflazine and dysrhythmia (author's transl)].
    Bergouignan J; Lefebvre D; Levol B; Ory J
    Ann Cardiol Angeiol (Paris); 1976; 25(2):155-60. PubMed ID: 1267401
    [No Abstract]   [Full Text] [Related]  

  • 8. Secondary prevention of ischemic heart disease: a long-term controlled lidoflazine study.
    De Geest H; Kesteloot H; Piessens J
    Acta Cardiol Suppl; 1979; (24):7-116. PubMed ID: 122040
    [No Abstract]   [Full Text] [Related]  

  • 9. [The effect of lidoflazine on the excitation process in the resting and stress ECG in coronary patients (author's transl)].
    Lehmann HU; Scholle J; Hochrein H
    MMW Munch Med Wochenschr; 1974 Nov; 116(46):2019-26. PubMed ID: 4141058
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ambulatory treatment experience with lidoflazine in ischemic heart disease].
    Pmerantsev VP; Ivanova NA; Zadionchenko VS; Vertkin AL; Martynov AI
    Kardiologiia; 1980 Jul; 20(7):109-10. PubMed ID: 7401433
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardioprotective effects of lidoflazine during 1-hour normothermic global ischemia.
    Flameng W; Daenen W; Borgers M; Thone F; Xhonneux R; van de Water A; van Belle H
    Circulation; 1981 Oct; 64(4):796-807. PubMed ID: 7273379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of lidoflazin in the treatment of ischemic heart disease].
    Fomina AA; Mironova KA; Glomozda NIa; Klimovich MD
    Vrach Delo; 1977 Mar; (3):68-71. PubMed ID: 855300
    [No Abstract]   [Full Text] [Related]  

  • 13. A double-blind placebo-controlled cross-over study with lidoflazine (Clinium) in post-infarction patients.
    Meilink-Hoedemaker LJ; Pool J; Muste-Heijns MM
    Acta Med Scand; 1976; 199(1-2):17-23. PubMed ID: 766572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial protection by lidoflazine during one-hour normothermic global ischemia.
    Daenen W; Flameng W
    Angiology; 1981 Aug; 32(8):543-51. PubMed ID: 7258731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antiarrhythmic properties of lidoflazine in the therapy of auricular fibrillation and flutter (clinical studies of 26 patients)].
    Lehmann HU; Hochrein H
    Z Kardiol; 1975 Aug; 64(8):741-8. PubMed ID: 1099831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postinfarction exercise capacity after lidoflazine treatment or physical training.
    Degré S; Lenaers A; Messin R; Vandermoten P; Salhadin P; Limage M; Denolin H
    Cardiology; 1979; 64(1):35-47. PubMed ID: 365332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Protective effects of lidoflazine and mioflazine in ischemic myocardium].
    Liu GS; Borgers M; Xhonneux R
    Zhonghua Xin Xue Guan Bing Za Zhi; 1988 Apr; 16(2):100-2, 127. PubMed ID: 3197595
    [No Abstract]   [Full Text] [Related]  

  • 18. [Controlled study oflidoflazine in ischemic heart disease].
    Demin AA; Balashov VA
    Kardiologiia; 1977 Dec; 17(12):125. PubMed ID: 340757
    [No Abstract]   [Full Text] [Related]  

  • 19. The influence of prolonged lidoflazine (R 7904) treatment on resting ECG, heart rate and blood pressure. A retrospective study.
    Bosmans P; Reinards J; Terrijn R; Vandervoort R
    Acta Cardiol; 1977; 32(2):87-97. PubMed ID: 302077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Non-homogenous irrigation of the myocardium and its importance in cardiac therapeutics].
    Schaper W
    Brux Med; 1973 Sep; 53(9):523-7. PubMed ID: 4202038
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.